Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
COVID-19 News New study finds strong immune response following COVID-19 vaccination A new study carried out in collaboration with the University of Birmingham with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.
COVID-19 New gene therapy innovation centre to advance scientific discoveries into life-changing treatments
Posted 26 November 2021 Researchers awarded vital funding to explore treatment to slow rare liver disease LifeArc and PSC Support jointly award £948,774 for new research into primary sclerosing cholangitis (PSC), a rare disease where the body attacks its own liver, causing inflammation and scarring of the bile ducts.
Posted 09 November 2021 Child cancer experts welcome gift for vital new research equipment University of Birmingham cancer experts have welcomed a £120,000 charity donation to purchase new equipment that will help to speed the development of new treatments which could save the lives of children and adults.
Posted 22 October 2021 A third of leukaemia patients do not generate any antibody response to two doses of COVID-19 vaccination, study shows A University of Birmingham-led study has shown that a third of patients with the most common type of leukaemia fail to generate any measurable antibody response following two doses of COVID-19 vaccination.
Posted 11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
Posted 16 September 2021 Research provides new insight into fundamental workings of the immune system in response to therapy to treat skin cancer New research suggests that skin cancer patients could have a better prognosis if their T cells send messages from five specific genes in their immune response to drugs given to treat the disease.
Posted 14 September 2021 University of Birmingham scientists in new COVID-19 study University of Birmingham researchers are part of a new study seeking to understand why some people become infected with COVID-19 after vaccination or prior infection while others do not.